PUBLIC COMPANY
save3H Bio Co Ltd
founded 2019 · 7 employees · Seongnam, KRupdated 1mo ago
3H Bio Co Ltd is a South Korean biotech developing first-in-class metabolic disease therapies, including a peptide-vaccine approach to obesity that targets apoB100 to inhibit fat accumulation in adipocytes via immune-system activation. Pipeline also extends to diabetes, fatty liver disease, and atherosclerosis.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
device 510k (1)
🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that